Patent · US Active

Fused ring heterocycle kinase modulators

US7829558B2 · kind B2 · utility

146Cited by
11References
35Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 22, 2008
Grant dateNov 9, 2010
Priority date
Expiry dateFeb 5, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides novel fused ring heterocycle kinase modulators and methods of using the novel fused ring heterocycle kinase modulators to treat diseases mediated by kinase activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.